These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 637081)

  • 41. [Fetomaternal alloimmunization: role of cordocentesis].
    Donner C; Kadri R; Heymans O; Lambermont M; Gosselin F; Rodesch F
    Rev Med Brux; 1992 Apr; 13(4):124-8. PubMed ID: 1594825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultrasound as an aid in intrauterine transfusion.
    Cooperberg PL; Carpenter CW
    Am J Obstet Gynecol; 1977 Jun; 128(3):239-41. PubMed ID: 871139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis].
    Hoch H; Giers G; Bald R; Hanfland P
    Beitr Infusionsther; 1992; 30():439-42. PubMed ID: 1284755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrauterine fetal transfusions for the management of erythroblastosis.
    Cherry SH; Rosenfield RE
    Am J Obstet Gynecol; 1967 May; 98(2):275-82. PubMed ID: 4960703
    [No Abstract]   [Full Text] [Related]  

  • 45. Percutaneous umbilical transfusion in severe rhesus isoimmunization: resolution of fetal hydrops.
    Socol ML; MacGregor SN; Pielet BW; Tamura RK; Sabbagha RE
    Am J Obstet Gynecol; 1987 Dec; 157(6):1369-75. PubMed ID: 3122574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
    Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V
    Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early intrauterine transfusion in severe red blood cell alloimmunization.
    Yinon Y; Visser J; Kelly EN; Windrim R; Amsalem H; Seaward PG; Ryan G
    Ultrasound Obstet Gynecol; 2010 Nov; 36(5):601-6. PubMed ID: 20509139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Progress in intrauterine transfusion. Prof. Hansmann, Bonn, on ultrasound-controlled fine needle puncture of the fetus].
    Hansmann M
    Fortschr Med; 1990 Sep; 108(26):18, 21. PubMed ID: 2124575
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results obtained in the management of materno-fetal isoimmunization to the Rh factor in the Hospital de Gineco-Obstetricia No. 3 of the Instituto Mexicano del Seguro Social].
    Avalos Calderón J; Díaz Esponda JC; Bravo Sandoval J; Ruiz Velasco V; Zárate Sandoval H; Ayllon Solórzano E; Elías Rosario H
    Ginecol Obstet Mex; 1973 Nov; 34(205):429-43. PubMed ID: 4784498
    [No Abstract]   [Full Text] [Related]  

  • 50. Amniotic fluid spectrophotometry, urinary estrogen estimations, and intrauterine transfusion in severe Rh isoimmunization.
    Bjerre S; Gold CC; Wilson R; Doran TA
    Am J Obstet Gynecol; 1968 Sep; 102(2):275-83. PubMed ID: 5675874
    [No Abstract]   [Full Text] [Related]  

  • 51. [Intrauterine blood transfusion as a method of treatment of the edematous form of hemolytic disease of newborn].
    Mikhaĭlov AV; Konstantinova NN; Pigina TV
    Akush Ginekol (Mosk); 1990 Jul; (7):41-5. PubMed ID: 2122758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rh hemolytic disease of the newborn.
    Page S
    Neonatal Netw; 1989 Jun; 7(6):31-41. PubMed ID: 2499756
    [No Abstract]   [Full Text] [Related]  

  • 53. Hydrops fetalis associated with immunologic and nonimmunologic factors.
    Vintzileos AM; Campbell WA; Deaton JL; Nochimson DJ; Weinbaum PJ
    Am J Perinatol; 1987 Apr; 4(2):115-20. PubMed ID: 3105548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
    Ovali F; Samanci N; Dağoğlu T
    Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultrasound-guided fetal intravascular transfusion in severe rhesus immunization.
    Seeds JW; Bowes WA
    Am J Obstet Gynecol; 1986 May; 154(5):1105-7. PubMed ID: 3085503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prenatal treatment of severe fetomaternal blood group incompatibilities].
    Brossard Y; Chavinié J; Poissonnier MH
    Rev Prat; 1984 Dec; 34(59):3309-14. PubMed ID: 6441239
    [No Abstract]   [Full Text] [Related]  

  • 58. Management of patients with Rh isoimmunization based on amniotic fluid examination.
    Robertson JG
    Am J Obstet Gynecol; 1969 Mar; 103(5):713-22. PubMed ID: 5766484
    [No Abstract]   [Full Text] [Related]  

  • 59. Management of isoimmunized pregnancy by use of intravascular techniques.
    Barss VA; Benacerraf BR; Frigoletto FD; Greene MF; Penso C; Saltzman DH; Nadel A; Heffner LJ; Scherl JE; Doubilet PM
    Am J Obstet Gynecol; 1988 Oct; 159(4):932-7. PubMed ID: 3177548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Intrauterine transfusion in severe fetal erythroblastosis. Results and methods--studies of 803 cases of the world literature].
    Pfleiderer A; Goblirsch H
    Med Welt; 1969 Feb; 5():232-7. PubMed ID: 4978482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.